Analysis shows Boston Naming Test accurately distinguishes valid from invalid responders in veterans, suggesting its effectiveness as a performance validity test.
Objective This study examined the effectiveness of the Boston Naming Test (BNT) as an embedded performance validity test (PVT) in a sample of Veterans who underwent neuropsychological evaluation at a VA medical center. We replicated Abramson et al.’s (2020) analytic approach to evaluate whether BNT scores distinguished between valid and invalid responders. Method Participants were 655 Veterans (88.1% male; 94.0% white; M/SD: age = 57.49/13.97; education = 13.17/2.34). Performance validity was determined by failure of > 2 PVTs. Cognitive impairment was determined by the presence of any neurocognitive disorder diagnosis. Participants were grouped as unimpaired-valid, unimpaired-invalid, impaired-valid, or impaired-invalid. BNT cutoffs were compared across groups using ANOVA. Accuracy was examined with Chi-square and receiver operating characteristic (ROC) analyses. Results BNT performance differed significantly across groups for both raw, F(3, 494) = 40.42, p < .001, and T-scores, F(3, 484) = 17.70, p < .001. A <= 50 raw score cutoff yielded 89.5% specificity and 64.4% sensitivity; a <= 18 T-score cutoff yielded 99.5% specificity and 3.5% sensitivity. ROC analyses showed good discrimination for the BNT raw score (AUC = .821) and fair discrimination for the T-score (AUC = .756). Conclusion These findings support the utility of the BNT—particularly the raw score cutoff—as a practical, embedded PVT with strong classification accuracy for Veterans.
No takes yet. Share an insight, caveat, or question.
Fiore et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: